Pathophysiological Mechanisms in Sclerosing Skin Diseases

Sclerosing skin diseases represent a large number of distinct disease entities, which include systemic sclerosis, localized scleroderma, and scleredema adultorum. These pathologies have a common clinical appearance and share histological features. However, the specific interplay between cytokines an...

Full description

Bibliographic Details
Main Authors: Beate Eckes, Fang Wang, Pia Moinzadeh, Nicolas Hunzelmann, Thomas Krieg
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-08-01
Series:Frontiers in Medicine
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fmed.2017.00120/full
id doaj-4f054e7ce003470389401d2cd808686c
record_format Article
spelling doaj-4f054e7ce003470389401d2cd808686c2020-11-24T22:56:46ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2017-08-01410.3389/fmed.2017.00120271491Pathophysiological Mechanisms in Sclerosing Skin DiseasesBeate Eckes0Fang Wang1Pia Moinzadeh2Nicolas Hunzelmann3Thomas Krieg4Thomas Krieg5Thomas Krieg6Department of Dermatology, University of Cologne, Cologne, GermanyDepartment of Dermatology, University of Cologne, Cologne, GermanyDepartment of Dermatology, University of Cologne, Cologne, GermanyDepartment of Dermatology, University of Cologne, Cologne, GermanyDepartment of Dermatology, University of Cologne, Cologne, GermanyCenter for Molecular Medicine (CMMC), Cologne, GermanyCluster of Excellence in Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, GermanySclerosing skin diseases represent a large number of distinct disease entities, which include systemic sclerosis, localized scleroderma, and scleredema adultorum. These pathologies have a common clinical appearance and share histological features. However, the specific interplay between cytokines and growth factors, which activate different mesenchymal cell populations and production of different extracellular matrix components, determines the biomechanical properties of the skin and the clinical features of each disease. A better understanding of the mechanisms underlying these events is prerequisite for developing novel targeted therapeutic approaches.http://journal.frontiersin.org/article/10.3389/fmed.2017.00120/fullsystemic sclerosisscleromyxedemascleredemastiff skin syndromenephrogenic systemic fibrosisextracellular matrix
collection DOAJ
language English
format Article
sources DOAJ
author Beate Eckes
Fang Wang
Pia Moinzadeh
Nicolas Hunzelmann
Thomas Krieg
Thomas Krieg
Thomas Krieg
spellingShingle Beate Eckes
Fang Wang
Pia Moinzadeh
Nicolas Hunzelmann
Thomas Krieg
Thomas Krieg
Thomas Krieg
Pathophysiological Mechanisms in Sclerosing Skin Diseases
Frontiers in Medicine
systemic sclerosis
scleromyxedema
scleredema
stiff skin syndrome
nephrogenic systemic fibrosis
extracellular matrix
author_facet Beate Eckes
Fang Wang
Pia Moinzadeh
Nicolas Hunzelmann
Thomas Krieg
Thomas Krieg
Thomas Krieg
author_sort Beate Eckes
title Pathophysiological Mechanisms in Sclerosing Skin Diseases
title_short Pathophysiological Mechanisms in Sclerosing Skin Diseases
title_full Pathophysiological Mechanisms in Sclerosing Skin Diseases
title_fullStr Pathophysiological Mechanisms in Sclerosing Skin Diseases
title_full_unstemmed Pathophysiological Mechanisms in Sclerosing Skin Diseases
title_sort pathophysiological mechanisms in sclerosing skin diseases
publisher Frontiers Media S.A.
series Frontiers in Medicine
issn 2296-858X
publishDate 2017-08-01
description Sclerosing skin diseases represent a large number of distinct disease entities, which include systemic sclerosis, localized scleroderma, and scleredema adultorum. These pathologies have a common clinical appearance and share histological features. However, the specific interplay between cytokines and growth factors, which activate different mesenchymal cell populations and production of different extracellular matrix components, determines the biomechanical properties of the skin and the clinical features of each disease. A better understanding of the mechanisms underlying these events is prerequisite for developing novel targeted therapeutic approaches.
topic systemic sclerosis
scleromyxedema
scleredema
stiff skin syndrome
nephrogenic systemic fibrosis
extracellular matrix
url http://journal.frontiersin.org/article/10.3389/fmed.2017.00120/full
work_keys_str_mv AT beateeckes pathophysiologicalmechanismsinsclerosingskindiseases
AT fangwang pathophysiologicalmechanismsinsclerosingskindiseases
AT piamoinzadeh pathophysiologicalmechanismsinsclerosingskindiseases
AT nicolashunzelmann pathophysiologicalmechanismsinsclerosingskindiseases
AT thomaskrieg pathophysiologicalmechanismsinsclerosingskindiseases
AT thomaskrieg pathophysiologicalmechanismsinsclerosingskindiseases
AT thomaskrieg pathophysiologicalmechanismsinsclerosingskindiseases
_version_ 1725653482038362112